<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Clinical trials — certain drugs</p><p class="Section transitional" id="1156125"><strong><a class="sectionLabel" id="s-180"><span class="sectionLabel">180</span></a></strong> A person that, immediately before the coming into force of section 166, is authorized under Division 5 of Part C of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/C.R.C.,_c._870">Food and Drug Regulations</a></cite> to sell or import a drug for the purposes of a clinical trial is deemed to be the holder, in respect of that drug, of an authorization referred to in section 3.1 of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by that section 166.</p>